Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer?

AIM To undertake a preliminary assessment of the potential for computed tomography (CT) measurement of tumour heterogeneity to stratify risk of nodal metastasis in patients with non-small cell lung cancer (NSCLC). MATERIALS AND METHODS Tumour heterogeneity in CT images from combined positron-emission tomography (PET)/CT examinations in 150 consecutive patients with NSCLC was assessed using CT texture analysis (CTTA). The short axis diameter of the largest mediastinal node was also measured. Forty-two patients without distant metastases subsequently had tumour nodal status confirmed at surgery (n=26) or endobronchial ultrasound (EBUS; n=16). CTTA parameters and largest nodal diameter were related to nodal status using the rank correlation and the risk ratio for each nodal stage (>N0, >N1, >N2) was compared between patients categorised as high and low risk by CTTA or nodal size. The most significant predictor of nodal status was related to overall survival using Kaplan-Meier analysis. RESULTS N-stage was more significantly correlated with CTTA than nodal diameter (Rs = -0.39, p=0.011, Rs = -0.45, p=0.0025, Rs = -0.40, p=0.0091 for normalised standard deviation (SD), normalised entropy and kurtosis respectively; Rs = -0.39, p=0.042 for nodal diameter). The presence of two or more high-risk CTTA values was the greatest risk factor for mediastinal metastasis (risk ratio: 11.0, 95% confidence interval: 1.56-77.8, p=0.0014) and was associated with significantly poorer overall survival (p=0.016). CONCLUSION CTTA in NSCLC is related to nodal status in patients without distant metastases and has the potential to inform selection of investigative strategies for the assessment of mediastinal malignancy.

[1]  Gregory Riely,et al.  Radiogenomic evaluation of lung cancer - Are there imaging characteristics associated with lung adenocarcinomas harboring BRAF mutations? , 2017, Clinical imaging.

[2]  I. Fidler,et al.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Massimo Bellomi,et al.  CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer , 2015, European Radiology.

[4]  Shota Yamamoto,et al.  ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization. , 2014, Radiology.

[5]  M. Shingyoji,et al.  Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer. , 2014, The Annals of thoracic surgery.

[6]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[7]  M. P. Hayball,et al.  CT texture analysis using the filtration-histogram method: what do the measurements mean? , 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

[8]  M. Brock,et al.  Staging lymph node metastases from lung cancer in the mediastinum. , 2014, Journal of thoracic disease.

[9]  R. Korn,et al.  Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic , 2014, PloS one.

[10]  Chaya S Moskowitz,et al.  Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? , 2014, Lung cancer.

[11]  O. Mawlawi,et al.  Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. , 2014, International journal of radiation oncology, biology, physics.

[12]  Olivier Gevaert,et al.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. , 2012, Radiology.

[13]  Simon Wan,et al.  Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer , 2013, Clinical Cancer Research.

[14]  K. Miles,et al.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.

[15]  Kenneth A. Miles,et al.  How to use CT texture analysis for prognostication of non-small cell lung cancer , 2016, Cancer Imaging.